Company · Healthtech & Bio

60Nd

www.60nd.bio ↗ ·Madrid ·Seed

60Nd is a deeptech spin-off of Universidad Carlos III de Madrid (UC3M) working in mechanobiology/mechanomedicine. It builds NeoMag, a portable device that combines magneto-active (magneto-intelligent) polymers with AI to apply programmable, non-invasive mechanical stimuli to 2D and 3D cell cultures, letting labs reproduce in vitro the mechanical conditions of pathologies such as tumours, brain trauma or tissue scarring. The company won a €2.4M EIC Transition grant under Horizon Europe (one of ~40 European deeptech projects selected), has raised over €3M in total including a ~€1.1M mix of private investment and public support (CDTI), and was a South Summit Madrid 2026 finalist in the Health category; its customers/users include UCL, Institut Pasteur, UCSF and CNIC.

Founded
2023
Founders
2
News
0
Rounds
1
Investors
1
SectorsHealthtech & Bio, Deeptech & Hardware, Biotech Instrumentation, Mechanobiology, AI & Data Start-up MapHealthtech & Bio › R&D tools & software for life sciences

Profile updated 31 Aug 2026

Founders

Daniel García González
Co-founder & Chief Scientific Officer (CSO)
Ricardo de la Torre González
Co-founder & CEO

Global models

No comparables on record yet.

Investors 1

Funding rounds 1

Other · €2.4M
60Nd, a spin-off of Universidad Carlos III de Madrid, was awarded a €2.4M EIC Transition grant to commercialise NeoMag, a magneto-intelligen…
2026-02-17

News & media

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close